Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-29

Use of Adipose Derived Stem Cells (ADSC) for Anal Incontinence Cell Therapy

Ziel

The possibility of improving the function of organs or structures damaged in numerous pathological scenarios by the use of cellular therapies is a true clinical reality. Stem cells isolated from adult tissues are one of the tools for this new therapeutic approach. Adipose Derived Stem Cells (ADSC) have shown multipotency in vitro (differentiation into fat, bone, cartilage, muscle). Several pre-clinical studies point to the use of ADSC in cell therapies.

Anal incontinence (AI) impacts severely the quality of life of sufferers, about 2-8% of the adult population. Injury to the pudendal nerve and/or to anal sphincter muscle from prior obstetric trauma is described as the primary risk factor to develop AI. The overall aim of this project is to develop a cell therapy for AI using ADSC in an animal model of anal sphincter deficiency.

We will develop a rat model of AI by simulated birth trauma (vaginal distension + episiotomy), and will characterize the structural and functional changes of the anal sphincter by in vitro, in vivo and ex vivo studies. Then we will test the effect of cells injected in the anal sphincter in the structural and functional restoration of the anal sphincter, comparing multipotent, undifferentiated ADSC with cells differentiated into a myogenic lineage.

This project is relevant to the objectives of the Human Resources and Mobility Work Programme. This project will allow the return of a first-class European researcher back into Europe and transfer the knowledge acquired in his last eight years of research in USA, effectively reversing and cancelling the European brain drain. The applicant will join a PRO, the Cell Therapy and Regenerative Unit of the Autonoma University of Madrid, which was established in 2004 through collaboration with a Spanish SME, Cellerix.

Thus, this project will benefit the applicant's career in the prospects of durable and stable professional integration and will improve the collaborative research between PROs and SMEs.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Thema/Themen

Aufforderung zur Vorschlagseinreichung

FP6-2004-MOBILITY-12
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

IRG - Marie Curie actions-International re-integration grants

Koordinator

FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PAZ
EU-Beitrag
Keine Daten
Adresse
Paseo de la Castellana 261
MADRID
Spanien
Gesamtkosten
Keine Daten